SCHEMBL5402953

SCHEMBL5402953

Cc1nc2cc(OC([C@@H](C)O)N3CCN(CCCCOc4ccc(Cl)cc4)CC3)ccc2s1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5400391 0.95 MEN1 (0.44) CYP3A4MEN1KMT2A
SCHEMBL5402852 0.92 CYP3A4 (0.47) CYP3A4
SCHEMBL5395174 0.90 CYP3A4 (0.47) CYP3A4
SCHEMBL5392373 0.89 SLC6A2 (0.42) CYP3A4
SCHEMBL5390514 0.89 CYP3A4 (0.43) CYP3A4
SCHEMBL6028986 0.89 CYP3A4 (0.43) CYP3A4
SCHEMBL5402921 0.88 SLC6A2 (0.41) CYP3A4
SCHEMBL5404154 0.87 DRD3 (0.45) CYP3A4
SCHEMBL5398561 0.87 CYP3A4 (0.48) CYP3A4
SCHEMBL5399874 0.87 HRH3 (0.44) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007514769-A 2007-06-07 JP claimed
EP-1723129-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2006-11-22 EP claimed
WO-2005061470-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-07-07 WO claimed
EP-1723129-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2006-11-22 EP disclosed
WO-2005061470-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-07-07 WO disclosed